Digital Pathology Software Improves Workflow Efficiency
|
By MedImaging International staff writers Posted on 31 Jan 2019 |

Image: uPath enterprise software provides improved digital pathology tools (Photo courtesy of Roche).
A novel software platform drastically decreases image-rendering times, integrates automated image analysis, and enables improved case sharing between pathologists.
The Roche (Basel, Switzerland) uPath enterprise software for digital pathology can help pathologists diagnose a patient case more quickly by viewing all slides in a single continuous view, as well as viewing all available patient information simultaneously. The multiple slides, which are presented on a canvas-like display, enabling seamless navigation between hematoxylin and eosin (HE), immunohistochemistry (IHC) and special stains in a single view, thanks to Leeds Virtual Microscope (LVM) technology, which is not possible with a standard microscope.
Analyses, both automated and manual, and slide markups are easily managed in the multi-slide viewer, while reporting features allow pathologists to aggregate notes, measurements, and slide scoring into easy-to-share images or PDFs. The customization offered through the uPath configurable interface and scalability allows pathologists to request second opinions and share cases in a fraction of the time that has traditionally been required, with no geographical limitations, unlike glass slides. LVM technology can also scale to display sizes ranging from laptops to high-definition wall screens.
"With this launch, we are able to deliver an improved digital pathology experience. We're excited to offer pathology labs a high-quality solution to help improve workflow efficiencies, accuracy, and precision tools,” said Jill German, Head of Roche Tissue Diagnostics. “This launch is another major milestone in our commitment to the advancement of patient care through digital pathology, empowering pathologists to deliver next-level personalized healthcare solutions.”
Digital pathology is an image-based information environment, which is enabled by computer technology, allowing for management of information generated from a digital slide. It is enabled in part by virtual microscopy, the conversion of glass slides into digital slides that can be viewed, managed, shared, and analyzed on a computer monitor. With the advent of whole-slide imaging, digital pathology is currently regarded as one of the most promising avenues of diagnostic medicine.
The Roche (Basel, Switzerland) uPath enterprise software for digital pathology can help pathologists diagnose a patient case more quickly by viewing all slides in a single continuous view, as well as viewing all available patient information simultaneously. The multiple slides, which are presented on a canvas-like display, enabling seamless navigation between hematoxylin and eosin (HE), immunohistochemistry (IHC) and special stains in a single view, thanks to Leeds Virtual Microscope (LVM) technology, which is not possible with a standard microscope.
Analyses, both automated and manual, and slide markups are easily managed in the multi-slide viewer, while reporting features allow pathologists to aggregate notes, measurements, and slide scoring into easy-to-share images or PDFs. The customization offered through the uPath configurable interface and scalability allows pathologists to request second opinions and share cases in a fraction of the time that has traditionally been required, with no geographical limitations, unlike glass slides. LVM technology can also scale to display sizes ranging from laptops to high-definition wall screens.
"With this launch, we are able to deliver an improved digital pathology experience. We're excited to offer pathology labs a high-quality solution to help improve workflow efficiencies, accuracy, and precision tools,” said Jill German, Head of Roche Tissue Diagnostics. “This launch is another major milestone in our commitment to the advancement of patient care through digital pathology, empowering pathologists to deliver next-level personalized healthcare solutions.”
Digital pathology is an image-based information environment, which is enabled by computer technology, allowing for management of information generated from a digital slide. It is enabled in part by virtual microscopy, the conversion of glass slides into digital slides that can be viewed, managed, shared, and analyzed on a computer monitor. With the advent of whole-slide imaging, digital pathology is currently regarded as one of the most promising avenues of diagnostic medicine.
Latest Imaging IT News
- Ambient AI Reporting Platform Streamlines Radiology Reporting
- Interactive AI Tool Supports Explainable Lung Nodule Assessment
- Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
- New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
- Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
- AI-Based Mammography Triage Software Helps Dramatically Improve Interpretation Process
- Artificial Intelligence (AI) Program Accurately Predicts Lung Cancer Risk from CT Images
- Image Management Platform Streamlines Treatment Plans
- AI-Based Technology for Ultrasound Image Analysis Receives FDA Approval
- AI Technology for Detecting Breast Cancer Receives CE Mark Approval
Channels
Radiography
view channel
AI Tool Predicts Five-Year Breast Cancer Risk from Mammograms
Breast cancer risk assessment during routine screening is difficult because many women who develop the disease have no known genetic mutations or family history. Static risk tools provide limited discrimination... Read more
AI Mammography Tools Detect Early Breast Cancer Signs Years Before Diagnosis
Breast cancer screening aims to detect tumors before symptoms develop, but subtle mammographic changes can appear years before diagnosis and may be missed during routine reads. Delayed detection can lead... Read moreMRI
view channel
Cardiac MRI Detects Hidden Heart Dysfunction After Heart Attack
Myocardial infarction often leaves patients with persistent ventricular dysfunction that can progress without obvious signs. Detecting early decline remains difficult because standard measures may miss... Read more
AI Tool Reveals Cortical Lesions on Standard MRI in Multiple Sclerosis
Multiple sclerosis (MS) causes immune-mediated damage in the brain that leads to disability and cognitive decline. Clinicians have long recognized that lesions in the brain’s gray matter, or cortex, are... Read moreUltrasound
view channel
Simple 2D Ultrasound Tool Accurately Estimates Placental Volume
Stillbirth remains a major cause of perinatal loss, with about 21,000 cases annually in the United States. Although placental abnormalities are linked to adverse pregnancy outcomes, routine monitoring... Read more
Portable 3D Ultrasound System Enables Reproducible Breast Cancer Monitoring
Breast cancer can develop between annual mammograms, and these interval cancers account for 20% to 30% of cases and tend to be more aggressive. The challenge is pronounced in people with dense breast tissue.... Read moreNuclear Medicine
view channel
Radiotherapy Professionals Embrace AI as a Clinical Support Tool
Radiotherapy planning requires precise identification of organs at risk near a tumor, but manual contouring is repetitive and time-consuming, often delaying plan completion and straining specialist capacity.... Read more
Second PSMA PET Identifies Disease in More Than Half of Negative Cases
Biochemical recurrence of prostate cancer after prostatectomy or radiation can be difficult to localize when imaging is negative. Uncertain disease sites may delay salvage therapy and expose patients to... Read moreGeneral/Advanced Imaging
view channel
Virtual Staining Technique Creates Histology Images from CT Data
Pulmonary hypertension, a disorder marked by pathological remodeling of the pulmonary vessels, often requires detailed histologic assessment. Yet routine pathology remains anchored in labor‑intensive,... Read more
CT-Derived Biomarker Predicts Outcomes in Gastric Cancer
Gastric cancer, also known as stomach cancer, is the fifth most common malignancy worldwide and often shows heterogeneous outcomes even within the same stage. Prognostic estimates typically rely on tumor-centric... Read more
AI Tool Enhances Response Assessment and Survival Prediction in Pleural Mesothelioma
Pleural mesothelioma, a cancer that grows as a thin, irregular layer along the lung wall, is difficult to measure on imaging. Clinicians rely on diameter-based Response Evaluation Criteria in Solid Tumors... Read moreIndustry News
view channel
GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026
Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
GE HealthCare Highlights AI-Supported Radiation Therapy Tools at ESTRO 2026
At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare is highlighting Intelligent Radiation Therapy (iRT), MIM Software innovations, and BK Medical surgical... Read more







